1985
DOI: 10.1001/archinte.1985.00360120142040
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic Hypomagnesemia During Cisplatin Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1997
1997
1997
1997

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…In this study the time elapsed between administration of cisplatin and appearance of In the 18 patients studied and despite that considerable time has passed since the arrest of cisplatin therapy, hypomagnesemia was approximately 15 days, a time shorter than that observed in adults [4,15]. Once hypoplasma Mg and UfMg were significantly lower than control values (1.5 Ϯ 0.21 mg/dl, P Ͻ 0.001; 1.02 Ϯ 0.16 magnesemia had developed it reappeared sooner and sooner after each cisplatin dose [27,28]. mg/dl, PϽ 0.01, respectively).…”
Section: Acute Effectsmentioning
confidence: 99%
“…In this study the time elapsed between administration of cisplatin and appearance of In the 18 patients studied and despite that considerable time has passed since the arrest of cisplatin therapy, hypomagnesemia was approximately 15 days, a time shorter than that observed in adults [4,15]. Once hypoplasma Mg and UfMg were significantly lower than control values (1.5 Ϯ 0.21 mg/dl, P Ͻ 0.001; 1.02 Ϯ 0.16 magnesemia had developed it reappeared sooner and sooner after each cisplatin dose [27,28]. mg/dl, PϽ 0.01, respectively).…”
Section: Acute Effectsmentioning
confidence: 99%